Dong Lü
Director/Board Member en Mudanjiang Youbo Pharmaceutical Co., Ltd. .
Perfil
Dong Lü is currently a Member-Supervisory Board at Mudanjiang Youbo Pharmaceutical Co., Ltd.
Previously, he was a Non-Executive Director at 3SBio, Inc. from 2014 to 2017.
He also held positions as a Director at Shenyang Sunshine Pharmaceuticals Co., Ltd., a Member-Supervisory Board at Jiuzhitang Co., Ltd., and a Vice President at CITIC Industrial Investment Group Corp.
Ltd.
Dr. Lü received a graduate degree from Peking University in 2003 and a doctorate degree from China Pharmaceutical University in 2010.
Cargos activos de Dong Lü
Empresas | Cargo | Inicio |
---|---|---|
Mudanjiang Youbo Pharmaceutical Co., Ltd.
Mudanjiang Youbo Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Mudanjiang Youbo Pharmaceutical Co., Ltd. is a holding company that manufactures and sells pharmaceutical products. It focuses on development of Chinese medicine. Its products include injection, lipid-lowering tablets, and lactobacillin tablets. The company was founded in October 1995 and is headquartered in Mudanjiang, China. | Director/Board Member | - |
Antiguos cargos conocidos de Dong Lü.
Empresas | Cargo | Fin |
---|---|---|
3SBIO INC. | Director/Board Member | 30/06/2017 |
JIUZHITANG CO., LTD. | Director/Board Member | - |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Director/Board Member | - |
CITIC Industrial Investment Group Corp. Ltd.
CITIC Industrial Investment Group Corp. Ltd. Financial ConglomeratesFinance CITIC Industrial Investment Group Corp. Ltd. engages in the investment in industries. It invests in elderly care service, agricultural, supply chain service of imported cards, trust, and aluminum wheel manufacturing enterprises. Its business activities include domestic trade, and information consulting services. The company was founded on November 11, 1988 and is headquartered in Shanghai, China. | Corporate Officer/Principal | - |
Formación de Dong Lü.
Peking University | Graduate Degree |
China Pharmaceutical University | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
3SBIO INC. | Health Technology |
JIUZHITANG CO., LTD. | Health Technology |
Empresas privadas | 3 |
---|---|
Mudanjiang Youbo Pharmaceutical Co., Ltd.
Mudanjiang Youbo Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Mudanjiang Youbo Pharmaceutical Co., Ltd. is a holding company that manufactures and sells pharmaceutical products. It focuses on development of Chinese medicine. Its products include injection, lipid-lowering tablets, and lactobacillin tablets. The company was founded in October 1995 and is headquartered in Mudanjiang, China. | Health Technology |
CITIC Industrial Investment Group Corp. Ltd.
CITIC Industrial Investment Group Corp. Ltd. Financial ConglomeratesFinance CITIC Industrial Investment Group Corp. Ltd. engages in the investment in industries. It invests in elderly care service, agricultural, supply chain service of imported cards, trust, and aluminum wheel manufacturing enterprises. Its business activities include domestic trade, and information consulting services. The company was founded on November 11, 1988 and is headquartered in Shanghai, China. | Finance |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Health Technology |
- Bolsa de valores
- Insiders
- Dong Lü